Heart valve patients get new hope in blood thinner trial
NCT ID NCT04045093
Summary
This study compares two blood-thinning drugs, Dabigatran and Warfarin, to see which is safer and more effective at preventing strokes in people with atrial fibrillation (an irregular heartbeat) who also have a narrowed heart valve called mitral stenosis. About 370 participants will be randomly assigned to take one of the two medications for a year. The goal is to gather evidence to help doctors choose the best stroke prevention treatment for this specific group of patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Hong Kong / Queen Mary Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.